Delivery Order SPE2DB22D3016-SPE2DB25FARL2
Award Date
3/17/25
Potential Completion Date
4/7/25
Potential Value
$8.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $34,018.40 contract is for the supply of 840 mg/14 ml vials of the cancer medication Tecentriq. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies in support of military...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TECENTRIQ 840 MG/14 ML VIAL 14ML. This $8,016.30 contract has a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors mentioned. The contract was awarded through DLA Troop Support Medical, which is responsible for supplying pharmaceuticals, medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of parent company Cencora, Inc. The $8,016.30 fixed-price delivery order is for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product. The award supports the DLA's mission to provide logistics and acquisition services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distributor, holds a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 840 mg/14 ml vials of the pharmaceutical product Tecentriq, with a potential value of $4,008.15 and a completion date of March 20, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide this medication to support military treatment programs and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $16,032.60 Firm Fixed Price Delivery Order contract is for the supply of 840 mg/14 ml vials of the cancer medication Tecentriq. The contract has an ultimate completion date of July 18, 2024. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
The Defense Logistics Agency awarded a $7,857.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561918282 TECENTRIQ 840 MG/14 ML VIAL 14ML pharmaceutical products. Amerisourcebergen Drug Corporation will deliver the products to a location in Conshohocken, Pennsylvania by September 14, 2023 under the terms of the order. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No subcontractors or set...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,824.28, is for the delivery of the specialty medication TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract has a firm fixed price pricing type and an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $26,019.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the product "TECVAYLI 153 MG/1.7 ML VIAL 1.7ML" and has a completion date of April 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical....
This federal contract award, valued at $1,141.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TECVAYLI 30 MG/3 ML VIAL 3ML, a pharmaceutical product, to support defense and military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 27, 2025. AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 MG/10 ML VIAL 10ML pharmaceutical products. The $20,560.00 firm-fixed-price contract has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...